Disruption of the hexokinase–VDAC complex for tumor therapy

Lorenzo Galluzzi; Oliver Kepp; Nicolas Tajeddine; Guido Guido Kroemer

doi:10.1038/onc.2008.114

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2009

Disruption of the PP1/GADD34 complex induces calreticulin exposure

Oliver Kepp, Lorenzo Galluzzi, Fabrizio Giordanetto, Antoine Tesnière, Ilio Vitale, Isabelle Martins, F. Schlemmer, Sandy Adjemian, Laurence Zitvogel, Guido Guido Kroemer

Article2021

Tumor-induced disruption of the blood-brain barrier promotes host death

Jung Kim, Hsiu‐Chun Chuang, Natalie K. Wolf, Christopher J. Nicolai, David H Raulet, Kaoru Saijo, David Bilder

Article2018

Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex

Loyanne Carla Barbosa Ramos, Fernando Postalli Rodrigues, Juliana C. Biazzotto, Sérgio de Paula Machado, Leonardo D. Slep, Michael R Hamblin, Roberto Santana da Silva

Article2025

Leveraging Tumor Microenvironment to Boost Synergistic Photodynamic Therapy, Ferroptosis Anti‐Tumor Efficiency Based on a Functional Iridium(III) Complex

Yutao Pei, Yinzhen Pan, Zhijun Zhang, Jun Zhu, Yan Sun, Qian Zhang, Dongxia Zhu, Guangzhe Li, Martin R. Bryce, Dong Wang, Ben Zhong Tang

Article2024

Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool

Daniel B. Rodrigues, Rui L Reis, Rogério P. Pirraco